Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Till

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Epidemiology and Infection|June 1, 1988
Factors affecting the toxicity of rotting carcasses containing Clostridium botulinum type EG R Smith, A Turner, D Till
Epidemiology and Infection|August 1, 1989
Necrobacillosis and immunity in miceG R Smith, L M Wallace, D Till
Epidemiology and Infection|June 1, 1989
Enhancement of the infectivity of Fusobacterium necrophorum by other bacteriaG R Smith, D Till, L M Wallace, et al.
Pharmacoeconomics|May 27, 1999
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthmaM P Rutten-van Mölken, E K van Doorslaer, M D Till
European Journal of Clinical Pharmacology|June 17, 1998
The extrapulmonary effects of increasing doses of formoterol in patients with asthmaC Burgess, M Ayson, S Rajasingham, et al.
Infection and Immunity|August 1, 1980
Immunity to pathogenic free-living amoebae: role of humoral antibodyR T Cursons, T J Brown, E A Keys, et al.
Infection and Immunity|August 1, 1980
Immunity to pathogenic free-living amoebae: role of cell-mediated immunityR T Cursons, T J Brown, E A Keys, et al.
European Journal of Radiology|January 3, 2019
Reduction of fluoroscopy dose for cardiac electrophysiology procedures: A feasibility and safety studyF Plank, B Stowasser, D Till, et al.
Social Science & Medicine (1982)|January 1, 1985
Maternal sociomedical characteristics and birth weights of firstbornsC Hoff, W Wertelecki, E Reyes, et al.
International Journal of Clinical Practice|June 23, 2004
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary diseaseJ F Muir, D Benhamou, A Cuvelier, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Epidemiology and Infection|June 1, 1988
Factors affecting the toxicity of rotting carcasses containing Clostridium botulinum type EG R Smith, A Turner, D Till
Epidemiology and Infection|August 1, 1989
Necrobacillosis and immunity in miceG R Smith, L M Wallace, D Till
Epidemiology and Infection|June 1, 1989
Enhancement of the infectivity of Fusobacterium necrophorum by other bacteriaG R Smith, D Till, L M Wallace, et al.
Pharmacoeconomics|May 27, 1999
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthmaM P Rutten-van Mölken, E K van Doorslaer, M D Till
European Journal of Clinical Pharmacology|June 17, 1998
The extrapulmonary effects of increasing doses of formoterol in patients with asthmaC Burgess, M Ayson, S Rajasingham, et al.
Infection and Immunity|August 1, 1980
Immunity to pathogenic free-living amoebae: role of humoral antibodyR T Cursons, T J Brown, E A Keys, et al.
Infection and Immunity|August 1, 1980
Immunity to pathogenic free-living amoebae: role of cell-mediated immunityR T Cursons, T J Brown, E A Keys, et al.
European Journal of Radiology|January 3, 2019
Reduction of fluoroscopy dose for cardiac electrophysiology procedures: A feasibility and safety studyF Plank, B Stowasser, D Till, et al.
Social Science & Medicine (1982)|January 1, 1985
Maternal sociomedical characteristics and birth weights of firstbornsC Hoff, W Wertelecki, E Reyes, et al.
International Journal of Clinical Practice|June 23, 2004
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary diseaseJ F Muir, D Benhamou, A Cuvelier, et al.
Pageof 2